Adicet Bio (ACET) Change in Taxes (2020 - 2021)
Adicet Bio (ACET) posted quarterly Change in Taxes of $2.6 million for Q4 2021, up 286.08% year-over-year from $661000.0 in Q4 2020, and up 4457.14% quarter-over-quarter from $56000.0 in Q3 2021.
Adicet Bio (ACET) Change in Taxes (2020 - 2021) Analysis & Trends
Adicet Bio's Change in Taxes history runs 2 years deep, the most recent figure standing at $2.6 million for Q4 2021.
- In Q4 2021, Change in Taxes rose 286.08% year-over-year to $2.6 million; the TTM figure through Dec 2022 stood at $2.6 million (down 5.71% YoY), while the FY2021 annual figure was $2.8 million, up 316.57% from the prior year.
- Change in Taxes for Q4 2021 stood at $2.6 million, up from $56000.0 in the prior quarter.
- The five-year high for Change in Taxes was $2.6 million in Q4 2021, with the low at $56000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.55 Mn |
| Dec 31, 2021 | 2.55 Mn |
| Sep 30, 2021 | 56,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Mar 31, 2021 | 158,000.00 |
| Mar 31, 2021 | 158,000.00 |
| Dec 31, 2020 | 661,000.00 |
| Dec 31, 2020 | 661,000.00 |